Stock data
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX) reported net income of -US$15.80M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | — | -US$15.80M | — |
| 2024 | — | — | — | -US$8.96M | — |
| 2023 | — | — | — | -US$8.69M | — |
| 2022 | — | — | — | -US$9.38M | — |
| 2021 | — | — | — | -US$21.46M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.37M | — |
| 2026-03-31 | — | -US$5.00M | — |
| 2025-12-31 | — | -US$4.35M | — |
| 2025-09-30 | — | -US$3.95M | — |
| 2025-06-30 | — | -US$3.70M | — |
| 2025-03-31 | — | -US$3.81M | — |
| 2024-12-31 | — | -US$2.31M | — |
| 2024-09-30 | — | -US$2.35M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.